Diadema Partners’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$770K Sell
100,660
-130,337
-56% -$996K 0.13% 93
2025
Q4
$2.25M Buy
+230,997
New +$1.96M 0.39% 59
2025
Q3
Sell
-32,483
Closed -$208K 158
2025
Q2
$302K Sell
32,483
-42,047
-56% -$367K 0.09% 85
2025
Q1
$727K Sell
74,530
-39,470
-35% -$488K 0.19% 71
2024
Q4
$1.38M Buy
+114,000
New +$1.39M 0.59% 44

Other funds holding REPL

Diadema Partners's REPL Position: Q1 2026 in Review

Diadema Partners reduced its Replimune Group (REPL) stake by 56% in Q1 2026, selling an estimated $996K and leaving 100,660 shares worth $770K. The position accounts for 0.13% of the portfolio, ranked #93.

Diadema Partners first reported a position in REPL in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.25M in Q4 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Diadema Partners held 100,660 shares of Replimune Group worth $770K as of Q1 2026.
  • Diadema Partners sold 130,337 Replimune Group shares in Q1 2026, an estimated $996K.
  • Replimune Group made up 0.13% of Diadema Partners's portfolio in Q1 2026, its #93 holding.
  • Diadema Partners first reported a position in Replimune Group in Q4 2024 and has held it in 5 quarters since.
  • Diadema Partners's Replimune Group position peaked at $2.25M in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Diadema Partners's 13F filing for Q1 2026, filed 15 May 2026.